| Biotechnology Industry | Healthcare Sector | Mr. Zhaowu Leng CEO | XSHE Exchange | CNE100005709 ISIN |
| CN Country | 655 Employees | 1 Jun 2026 Last Dividend | 4 Aug 2016 Last Split | - IPO Date |
Founded in 2004 and headquartered in Shanghai, China, Shanghai Universal Biotech Co., Ltd. specializes in the distribution and supply of antibodies and protein products. The company has established itself as a key player in the biotechnology sector, providing a wide range of products and services to various institutions including colleges and universities, research institutes, hospitals, and biomedical companies. Recognizing the importance of both product quality and scientific support, Shanghai Universal Biotech Co.,Ltd. is committed to advancing the scientific community's efforts in research and development through its offerings and expertise. In addition to its physical products, the company also embraces the digital age by selling its products online, ensuring accessibility and convenience for its global clientele.